LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

Search

Medpace Holdings Inc

Suletud

SektorTervishoid

306.35 0.19

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

301.79

Max

310.11

Põhinäitajad

By Trading Economics

Sissetulek

-2.4M

115M

Müük

22M

559M

P/E

Sektori keskmine

23.357

56.602

Aktsiakasum

3.67

Kasumimarginaal

20.516

Töötajad

5,900

EBITDA

-4.9M

120M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+4.09% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

21. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-162M

8.8B

Eelmine avamishind

306.16

Eelmine sulgemishind

306.35

Uudiste sentiment

By Acuity

50%

50%

372 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Medpace Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. mai 2025, 20:54 UTC

Omandamised, ülevõtmised, äriostud

PNC to Buy Private-Equity Agent Aqueduct Capital

20. mai 2025, 20:50 UTC

Tulu

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

20. mai 2025, 23:48 UTC

Omandamised, ülevõtmised, äriostud

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

20. mai 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

20. mai 2025, 23:39 UTC

Market Talk

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

20. mai 2025, 23:08 UTC

Market Talk

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

20. mai 2025, 22:46 UTC

Omandamised, ülevõtmised, äriostud

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

20. mai 2025, 22:45 UTC

Omandamised, ülevõtmised, äriostud

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

20. mai 2025, 22:20 UTC

Peamised uudised

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

20. mai 2025, 22:00 UTC

Tulu

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

20. mai 2025, 22:00 UTC

Tulu

ZTO Express (Cayman) 1Q EPS 34c >ZTO

20. mai 2025, 22:00 UTC

Tulu

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

20. mai 2025, 21:44 UTC

Tulu

James Hardie Industries 4Q Adj EPS 36c >JHX

20. mai 2025, 21:44 UTC

Tulu

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

20. mai 2025, 21:44 UTC

Tulu

James Hardie Industries 4Q EPS 10c >JHX

20. mai 2025, 21:44 UTC

Tulu

James Hardie Industries 4Q Sales $972M >JHX

20. mai 2025, 20:52 UTC

Peamised uudised

Elon Musk to Cut Back Political Spending -- 3rd Update

20. mai 2025, 20:52 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. mai 2025, 20:52 UTC

Market Talk

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

20. mai 2025, 20:30 UTC

Omandamised, ülevõtmised, äriostud

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

20. mai 2025, 20:28 UTC

Omandamised, ülevõtmised, äriostud

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

20. mai 2025, 20:23 UTC

Omandamised, ülevõtmised, äriostud

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

20. mai 2025, 20:22 UTC

Tulu

XP 1Q Adj EPS BRL2.29 >XP

20. mai 2025, 20:22 UTC

Tulu

XP 1Q Rev BRL4.345B >XP

20. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

20. mai 2025, 20:20 UTC

Peamised uudised

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

20. mai 2025, 20:19 UTC

Omandamised, ülevõtmised, äriostud

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

20. mai 2025, 20:11 UTC

Peamised uudised

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

20. mai 2025, 20:09 UTC

Tulu

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

20. mai 2025, 20:08 UTC

Tulu

Palo Alto Networks Sees FY25 Adj EPS $3.26-Adj EPS $3.28 >PANW

Võrdlus sarnastega

Hinnamuutus

Medpace Holdings Inc Prognoos

Hinnasiht

By TipRanks

4.09% tõus

12 kuu keskmine prognoos

Keskmine 318.5 USD  4.09%

Kõrge 355 USD

Madal 285 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Medpace Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

7 ratings

1

Osta

6

Hoia

0

Müü

Tehniline skoor

By Trading Central

300 / 302.88Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

372 / 382 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.